0001437749-19-022492.txt : 20191112 0001437749-19-022492.hdr.sgml : 20191112 20191112165012 ACCESSION NUMBER: 0001437749-19-022492 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20191108 FILED AS OF DATE: 20191112 DATE AS OF CHANGE: 20191112 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Morton Mawae CENTRAL INDEX KEY: 0001715607 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-14602 FILM NUMBER: 191210391 MAIL ADDRESS: STREET 1: 7473 MAKA'A STREET CITY: HONOLULU STATE: HI ZIP: 96825 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CYANOTECH CORP CENTRAL INDEX KEY: 0000768408 STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833] IRS NUMBER: 911206026 STATE OF INCORPORATION: NV FISCAL YEAR END: 0331 BUSINESS ADDRESS: STREET 1: 73-4460 QUEEN KAAHUMANU HWY STREET 2: SUITE 102 CITY: KAILUA KONA STATE: HI ZIP: 96740 BUSINESS PHONE: 8083261353 MAIL ADDRESS: STREET 1: 73-4460 QUEEN KAAHUMANU HWY STREET 2: SUITE 102 CITY: KAILUA-KONA STATE: HI ZIP: 96740 4 1 rdgdoc.xml FORM 4 X0306 4 2019-11-08 1 0000768408 CYANOTECH CORP CYAN 0001715607 Morton Mawae 73-4460 QUEEN KAAHUMANU HWY #102 KAILUA-KONA HI 96740 1 Former CEO and Director Common Stock 2019-11-08 4 A 0 5700 0 A 26605 D Common Stock 2019-11-08 4 D 0 1444 0 D 25161 D Stock Options 3.3500 Common Stock 75000 75000 D Stock Options 3.8300 Common Stock 45000 45000 D Grant of shares made pursuant to the Separation Agreement between the issuer and the reporting person, dated as of June 3, 2019 (the "Separation Agreement"), a copy of which is attached to and made a part of the issuer's Current Report on Form 8-K, filed with the Securities and Exchange Commission on June 7, 2019; transaction exempt from Section 16(b) of the Securitities Exchange Act of 1934, as amended (the "Exchange Act"), pursuant to Rule 16b-3 thereunder. Shares withheld pursuant to the Separation Agreement to satisfy tax withholding obligations; transaction exempt from Section 16(b) of the Exchange Act pursuant to Rule 16b-3 thereunder. Pursuant to Separation Agreement, all stock options are fully vested as of May 22, 2019. Pursuant to Separation Agreement, all stock options will expire on December 6, 2019. /s/Laura L. Taylor, by Power of Attorney 2019-11-12